Financhill
Back

Tecan Group AG Quote, Financials, Valuation and Earnings

Tecan Group AG Price Quote

$277.00

Tecan Group AG Key Stats

Sell
26
Tecan Group AG (TCHBF) is a Sell

Day range:
$277.00 - $277.00
52-week range:
$277.00 - $400.00
Dividend yield:
1.19%
P/E ratio:
24.15
P/S ratio:
3.18
P/B ratio:
2.27%

Volume:
0
Avg. volume:
0
1-year change:
-17.74%
Market cap:
$3.6B
Revenue:
$1.2B
EPS:
$8.86

How Much Does Tecan Group AG Make?

Is Tecan Group AG Growing As A Company?

Data Unavailable

Tecan Group AG Stock Price Performance

  • Did Tecan Group AG Stock Go Up Last Month?
    Tecan Group AG share price went up by 0% last month
  • Did TCHBF's Share Price Rise Over The Last Year?
    TCHBF share price fell by -17.74% over the past 1 year

What Is Tecan Group AG 52-Week High & Low?

Tecan Group AG Price To Free Cash Flow

Is It Risky To Buy Tecan Group AG?

  • How Much Debt Does Tecan Group AG Have?
    Total long term debt quarterly is $278M
  • How Much Cash Does Tecan Group AG Have?
    Cash and short term investments quarterly total is $382.4M
  • What Is Tecan Group AG’s Book Value Per Share?
    Book value per share is 122.33

Is Tecan Group AG Cash Flow Positive?

  • What Is TCHBF Cash Flow From Operations?
    Cash flow from operations (TTM) is $136.2M
  • What Is Tecan Group AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$72.4M
  • What Is Tecan Group AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$79M

Tecan Group AG Return On Invested Capital

  • Is Management Doing A Good Job?
    TCHBF return on invested capital is 6.19%
  • What Is Tecan Group AG Return On Assets?
    ROA measures how assets are converting to revenues and is 4.79%
  • What Is TCHBF Return On Equity?
    ROE is a measure of profitability and is 7.32%

Tecan Group AG Earnings Date & Stock Price

Tecan Group AG Competitors

  • Who Are Tecan Group AG's Competitors?
    Below is a list of companies who compete with Tecan Group AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

Tecan Group AG Dividend Yield

Tecan Group AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many TCHBF shares are owned by institutional investors?
    7.4M TCHBF shares are owned by institutional investors
  • How many TCHBF shares are owned by insiders?
    0 TCHBF shares are owned by insiders